Related Experiment Video
Updated: Mar 27, 2026

06:47
One-step Protocol for Evaluation of the Mode of Radiation-induced Clonogenic Cell Death by Fluorescence Microscopy
Published on: October 23, 2017
12.0K
Nonlinearity in MCF7 Cell Survival Following Exposure to Modulated 6 MV Radiation Fields: Focus on the Dose Gradient
Laetitia Lacoste-Collin1, Marion Castiella1, Xavier Franceries2
1Laboratoire d'Histologie-Embryologie, Faculté de Médecine Rangueil, Toulouse, France.
Dose-Response : a Publication of International Hormesis Society
|January 8, 2016
Summary
Nonuniform radiation fields show nonlinear cell survival effects. Even low doses in the gradient zone increased survival, highlighting critical radiotherapy considerations.
Area of Science:
- Radiation Oncology
- Cell Biology
- Cancer Research
Background:
- Nonuniform radiation fields are increasingly studied due to nonlinear dose-response relationships at low doses.
- Understanding cell survival in these complex fields is crucial for effective radiotherapy.
Purpose of the Study:
- To investigate in vitro cell survival in nonuniform radiation fields using the MCF7 breast cancer cell line.
- To analyze cell survival within the irradiation field, dose gradient zone, and peripheral zone.
Main Methods:
- MCF7 cells were exposed to 6 MV photons in a nonuniform field using a Varian Novalis accelerator.
- Cell survival was assessed using a clonogenic assay at various doses and locations within the T25 flask.
Main Results:
- Increased cell survival was observed within the irradiation area (2, 10, 20 Gy) when peripheral cells were present.
- Peripheral cells showed decreased survival compared to controls.
- Cells at the edge of the dose gradient zone (0.01-0.02 Gy) exhibited increased survival compared to peripheral cells.
Conclusions:
- This study provides the first data on cell survival within the dose gradient zone of nonuniform radiation fields.
- Radiotherapists must recognize and account for this observed nonlinearity in dose response for patient safety and treatment efficacy.

